1. Hu, Pengbo, Zhang, Xiuyuan, Li, Yiming, Xu, Liang, Qiu, Hong. 2022. Pan-Cancer Analysis of OLFML2B Expression and Its Association With Prognosis and Immune Infiltration. In Frontiers in genetics, 13, 882794. doi:10.3389/fgene.2022.882794. https://pubmed.ncbi.nlm.nih.gov/35873458/
2. Lin, Jiaxing, Xu, Xiao, Li, Tianren, Zhu, Yuyan, Sun, Dan. 2021. OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts. In Frontiers in oncology, 11, 650678. doi:10.3389/fonc.2021.650678. https://pubmed.ncbi.nlm.nih.gov/34868901/
3. Loh, Amos H P, Angelina, Clara, Wong, Meng Kang, Lim, Chwee Teck, Chen, Zhi Xiong. 2022. Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse. In Frontiers in oncology, 12, 939460. doi:10.3389/fonc.2022.939460. https://pubmed.ncbi.nlm.nih.gov/36176417/
4. Pérez-Ibave, Diana Cristina, González-Alvarez, Rafael, de La Luz Martinez-Fierro, Margarita, Barrera-Saldaña, Hugo Alberto, Rodríguez-Sánchez, Irám Pablo. 2016. Olfactomedin-like 2 A and B (OLFML2A and OLFML2B) expression profile in primates (human and baboon). In Biological research, 49, 44. doi:. https://pubmed.ncbi.nlm.nih.gov/27821182/
智鼠故事 
